Broad Institute

  • Read more: Opportunities and challenges for user-generated licensing models in gene-editing
    Article

    Opportunities and challenges for user-generated licensing models in gene-editing

    By Timo Minssen,  Esther van Zimmeren & Jakob Wested  An earlier version of this contribution had been published in Life Science Intellectual Property Review (LSIPR). A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through…

  • Read more: Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?
    Article

    Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?

    By  Jakob Wested, Timo Minssen & Esther van Zimmeren Another version of this contribution has been published in Life Science Intellectual Property Review (LSIPR). The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the European Patent Office (EPO). Ultimately, some of the issues might still be referred…